Common carotid intima-media thickness as a risk factor for outcomes in Asian patients with acute ST-elevation

Sahmin Lee1, Goo-Yeong Cho2, Hyun-Sook Kim3

  • 1Cardiovascular Center, Seoul National University Hospital, Republic of Korea.

Insights

Carotid intima-media thickness (CIMT) predicts cardiovascular events in Asian patients with ST-elevation myocardial infarction (STEMI). Higher CIMT indicates a worse prognosis, aiding in risk stratification for these patients.

Area of Science:

  • Cardiology
  • Vascular Ultrasound
  • Cardiovascular Disease Research

Background:

  • Carotid intima-media thickness (CIMT) is a known cardiovascular disease risk factor.
  • The prognostic value of CIMT in Asian patients with acute ST-elevation myocardial infarction (STEMI) was previously unclear.

Purpose of the Study:

  • To investigate whether CIMT can predict the prognosis of Asian patients diagnosed with STEMI.
  • To assess the association between CIMT and major adverse cardiovascular events (MACE) in this population.

Main Methods:

  • Prospective study of 345 STEMI patients (mean age 59 years) undergoing emergent revascularization.
  • Common CIMT measured via high-resolution ultrasonography; patients followed for a median of 583 days.
  • Primary endpoint: MACE (cardiovascular death, heart failure, recurrent MI, revascularization, stroke).

Main Results:

  • Mean CIMT was 0.77 ± 0.14 mm; 20.6% had carotid plaque, 11.0% experienced MACE.
  • Higher CIMT tertiles (≥ 0.83 mm) were associated with increased MACE rates (19.0% vs. 4.3% for lowest tertile).
  • CIMT and carotid plaque independently predicted overall MACE; CIMT tertile showed superior predictive value over other clinical factors (ROC AUC 0.69).

Conclusions:

  • CIMT is a valuable prognostic marker for predicting future cardiovascular events in Asian STEMI patients.
  • CIMT measurement can enhance risk stratification beyond traditional factors in this demographic.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
650